|
|
|
Press Releases
All Releases
 |
Harvard Bioscience, Inc. Announces Participation in the Regenerative Medicine Insight Track at the Biotech Showcase
Jan 9, 2012
|
12.7 KB |
|
| |
HOLLISTON, Mass., Jan. 9, 2012 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), today announced that David Green, President, will be participating in a panel session at the Regenerative Medicine Insight Track at the Biotech Showcase.
The following are specific details regarding Harvard Bioscience's participation at the conference:Reg...
|
|
Harvard Bioscience's "InBreath" Bioreactor Used in World's Second Successful Synthetic Trachea Transplant
Nov 29, 2011
|
16.5 KB |
|
| |
HOLLISTON, Mass., Nov. 29, 2011 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, announces that its "InBreath" bioreactor was used for the world's second successful transplantation of a synthetic tissue-eng...
|
|
Harvard Bioscience's InBreath Bioreactor Highlighted in Article in The Lancet Summarizing the World's First Synthetic Trachea Transplant
Nov 28, 2011
|
14.7 KB |
|
| |
HOLLISTON, Mass., Nov. 28, 2011 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, was highlighted in an article published in The Lancet, a leading peer-reviewed medical journal. The article described the wor...
|
|
HBIO Reports Third Quarter 2011 Results
Nov 3, 2011
|
52.5 KB |
|
| |
HOLLISTON, Mass., Nov. 3, 2011 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, today reported unaudited financial highlights for the three and nine months ended September 30, 2011.Third Quarter Reported Re...
|
|
Harvard Bioscience, Inc. Schedules Third Quarter 2011 Conference Call for November 3, 2011
Oct 28, 2011
|
12.5 KB |
|
| |
HOLLISTON, Mass., Oct. 28, 2011 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of specialized products used to advance life science research and regenerative medicine, will announce results for the third quarter ended September 30, 2011 before market trading hours on Thursd...
|
|
HBIO President David Green to Present at the UBS 2011 Global Life Sciences Conference
Sep 12, 2011
|
11.0 KB |
|
| |
HOLLISTON, Mass., Sept. 12, 2011 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of specialized products used to advance life science research and regenerative medicine, today announced that its President, David Green, will present at the UBS 2011 Life Sciences Conference on...
|
|
HBIO Reports Second Quarter 2011 Revenue Growth of 5% Over Second Quarter 2010
Aug 4, 2011
|
47.3 KB |
|
| |
HOLLISTON, Mass., Aug. 4, 2011 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, today reported unaudited financial highlights for the three and six months ended June 30, 2011.Second Quarter Reported Results...
|
|
Harvard Bioscience, Inc. Schedules Second Quarter 2011 Conference Call for August 4, 2011
Jul 28, 2011
|
12.8 KB |
|
| |
HOLLISTON, Mass., July 28, 2011 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of specialized products used to advance life science research and regenerative medicine, will announce results for the second quarter ended June 30, 2011 before market trading hours on Thursday, ...
|
|
Photo Release -- Harvard Bioscience's Bioreactor Grows a Synthetic Tissue-Engineered Trachea Used in World's First Successful Human Transplantation
Jul 7, 2011
|
14.5 KB |
|
| |
HOLLISTON, Mass., July 7, 2011 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of tools to advance life science research and regenerative medicine, announces that its "InBreath" bioreactor was used for the world's first successful transplantation of a synthetic tissue engine...
|
|
Harvard Bioscience, Inc. Acquires CMA Microdialysis' Preclinical Business
Jul 1, 2011
|
13.4 KB |
|
| |
HOLLISTON, Mass., July 1, 2011 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, today announced that it has acquired the preclinical business unit of CMA Microdialysis AB through a purchase of assets.
C...
|
|
Harvard Bioscience Ranked Massachusetts' #1 Biotech Company in Boston Globe 100
May 19, 2011
|
11.0 KB |
|
| |
HOLLISTON, Mass., May 19, 2011 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO) has been ranked the number one biotech company in Massachusetts in the 2011 Boston Globe 100, the Boston Globe's annual survey of the best-performing public companies headquartered in Massachusetts. Harvard Bioscience has also been ranked number 10 out of all ...
|
|
HBIO Reports First Quarter 2011 Revenues in Line With Guidance
Apr 28, 2011
|
39.8 KB |
|
| |
HOLLISTON, Mass., April 28, 2011 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, today reported unaudited financial highlights for the first quarter ended March 31, 2011.First Quarter Reported Results
...
|
|
TheStreet.com Features Harvard Bioscience in Video Segment Titled "Growing Organs - Growing Sales"
Apr 21, 2011
|
14.2 KB |
|
| |
HOLLISTON, Mass., April 21, 2011 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of tools to advance life science research and regenerative medicine, was featured on TheStreet.com in a video interview titled "Growing Organs - Growing Sales" on April 18, 2011.
"We are not...
|
|
Harvard Bioscience, Inc. Schedules First Quarter 2011 Conference Call for April 28, 2011
Apr 21, 2011
|
12.8 KB |
|
| |
HOLLISTON, Mass., April 21, 2011 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of specialized products used to advance life science research and regenerative medicine, will announce results for the first quarter ended March 31, 2011 before market trading hours on Thursday,...
|
|
HBIO Reports 26% Revenue Growth
Feb 25, 2011
|
52.6 KB |
|
| |
HOLLISTON, Mass., Feb. 25, 2011 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, today reported unaudited financial highlights for the fourth quarter and full year ended December 31, 2010.Fourth Quarter Rep...
|
|
Harvard Bioscience, Inc. Schedules Fourth Quarter 2010 Conference Call for February 25, 2011
Feb 24, 2011
|
12.2 KB |
|
| |
HOLLISTON, Mass., Feb. 24, 2011 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of specialized products used to advance life science research and regenerative medicine, will announce results for its fourth quarter and year ended December 31, 2010 before market trading hours ...
|
|
National Geographic Channel Features Harvard Bioscience Bioreactor Technology for Organ Regeneration
Feb 11, 2011
|
14.0 KB |
|
| |
HOLLISTON, Mass., Feb. 11, 2011 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of specialized products used to advance life science research and regenerative medicine, is pleased to announce that its novel bioreactor technology was featured on the National Geographic Channe...
|
|
PBS's Nova ScienceNow Features Harvard Bioscience Bioreactors for Lung and Airway Regeneration
Feb 8, 2011
|
13.4 KB |
|
| |
HOLLISTON, Mass., Feb. 8, 2011 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of specialized products used to advance life science research and regenerative medicine, is pleased to announce that its LB2 Lung Regeneration Bioreactor was featured on PBS's Nova ScienceNow tele...
|
|
Harvard Bioscience Files Two Major Patents in Field of Regenerative Medicine
Dec 9, 2010
|
12.8 KB |
|
| |
HOLLISTON, Mass., Dec. 9, 2010 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. ("Harvard Bioscience," or the "Company") (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of specialized products used to advance life science research and regenerative medicine, has filed two major patents in the field of regenerative medicine,...
|
|
Cellectis Grants Harvard Bioscience a License to CytoPulse Electroporation Instruments
Dec 2, 2010
|
15.8 KB |
|
| |
PARIS and HOLLISTON, Mass., Dec. 2, 2010 (GLOBE NEWSWIRE) -- Cellectis (Alternext:ALCLS), the French genome engineering specialist, and Harvard Apparatus, a division of Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, have ann...
|
|
|
=add release to Briefcase Disclaimer:
The information contained within this and other Harvard Bioscience Web pages should be deemed accurate and current as of the date of the most recent update, or if no update information has been provided, the date of issuance. Harvard Bioscience assumes no responsibility for any misincurrances or misstatements which occur as the result of the reading of dated material. Users are strongly encouraged to check dates of issuance and most recent update of any information contained within, or linked to, Harvard Bioscience’s web site. For Harvard Bioscience’s most current information please reference Harvard Bioscience public filings with the Securities and Exchange Commission located at http://www.sec.gov.
|
|
|
